Jenscare Scientific Co., Ltd.

Innovation Spirits

We have independently developed 10 minimally invasive interventional treatment solutions targeting tricuspid valve diseases, mitral valve diseases, aortic valve diseases, and heart failure. All products are based on our original innovation and possess global patents and independent intellectual property rights.

Scroll

Home > Products > Detail

MicroFlux AlginSys & EndoInjex

MicroFlux

房间隔造孔支架系统

MicroFlux is our proprietary first-generation transcatheter device for the treatment of HFpEF. It works by creating a small opening in the atrial septum, and once MicroFlux is deployed, it forms a passage between the left and the right atrium that enables the left atrium to decompress at rest and physical activity, with the aim of lowering left atrial pressure.

Patent layout

Application No	Patent name	Application Type	State
201922261026.2	一种可控释放的系统	实用新型	授权

About Us

Products

Business

R&D and Production

News Center

Investor Relations

Careers

Contact